Metabolic surgery;Metabolische Chirurgie

Chirurg

Volumn 83, Issue 6, 2012, Pages 583-600

  Jurowich, C ^a   Germer, C T ^a   Seyfried, F ^a   Thalheimer, A ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Bariatric surgery; Comorbidities; Diabetes remission; Metabolic surgery; Type 2 diabetes mellitus

Indexed keywords

ARTICLE; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BODY WEIGHT; COMPARATIVE STUDY; FOLLOW UP; GASTROPLASTY; GLUCOSE BLOOD LEVEL; HUMAN; INTESTINE ABSORPTION; LAPAROSCOPY; METABOLISM; METHODOLOGY; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL REQUIREMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; RISK FACTOR; STOMACH BYPASS;

BARIATRIC SURGERY; BILIOPANCREATIC DIVERSION; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; FOLLOW-UP STUDIES; GASTRIC BYPASS; GASTROPLASTY; HUMANS; INTESTINAL ABSORPTION; LAPAROSCOPY; NUTRITIONAL REQUIREMENTS; OBESITY, MORBID; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 84862486960     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-011-2239-9     Document Type: Article

References (94)

1. Dixon JB, Zimmet P, Alberti KG et al (2011) Bariatric surgery: an IDF statement for obese Type 2 diabetes (1). Diabet Med 28: 628-642
2. Gregg EW, Cheng YJ, Narayan KM et al (2007) The relative contributions of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976-2004. Prev Med 45:348-352
3. Ariza MA, Vimalananda VG, Rosenzweig JL (2010) The economic consequences of diabetes and cardiovascular disease in the United States. Rev Endocr Metab Disord 11:1-10
4. Buchwald H (2010) Surgery on obese patients. J Am Coll Surg 210:1012- 1013
5. Runkel N, Colombo-Benkmann M, Huttl TP et al (2011) Evidence-based German guidelines for surgery for obesity. Int J Colorectal Dis 26:397-404
6. Suter M, Paroz A, Calmes JM et al (2006) European experience with laparoscopic Roux-en-Y gastric bypass in 466 obese patients. Br J Surg 93:726- 732
7. Meneghini LF (2007) Impact of bariatric surgery on type 2 diabetes. Cell Biochem Biophys 48:97-102
8. Rubino F (2008) Is Type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care 31:290-296
9. Buchwald H, Oien DM (2009) Metabolic/bariatric surgery worldwide 2008. Obes Surg 19:1605-1611
10. Fried M, Ribaric G, Buchwald JN et al (2010) Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35 kg/m2: An integrative review of early studies. Obes Surg 20:776-790
11. Mingrone G, Panunzi S, De Gaetano A et al (2012) Bariatric surgery versus conventional medical therapy for Type 2 diabetes. N Engl J Med (in press)
12. Schauer PR, Kashyap SR, Wolski K et al (2012) Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med (in press)
13. Kremen AJ, Linner JH, Nelson CH (1954) An experimental evaluation of the nutritional importance of proximal and distal small intestine. Ann Surg 140:439-448
14. Buchwald H, Varco RL (1971) A bypass operation for obese hyperlipidemic patients. Surgery 70:62-70
15. Buchwald H, Buchwald JN (2002) Evolution of operative procedures for the management of morbid obesity 1950- 2000. Obes Surg 12:705-717
16. Suter M, Donadini A, Romy S et al (2011) Laparoscopic Roux-en-Y gastric bypass: significant long-term weight loss, improvement of obesity-related comorbidities and quality of life. Ann Surg 254:267-273
17. Higa K, Ho T, Tercero F et al (2011) Laparoscopic Roux-en-Y gastric bypass: 10-year follow-up. Surg Obes Relat Dis 7:516-525
18. Christou NV (2009) Impact of obesity and bariatric surgery on survival. World J Surg 33:2022-2027
19. Sjostrom L, Narbro K, Sjostrom CD et al (2007) Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357:741-752
20. Buchwald H, Estok R, Fahrbach K et al (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122:248- 256
21. Buse JB, Caprio S, Cefalu WT et al (2009) How do we define cure of diabetes? Diabetes Care 32:2133-2135
22. Hall TC, Pellen MG, Sedman PC et al (2010) Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg 20:1245-1250
23. Hamza N, Abbas MH, Darwish A et al (2011) Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass. Surg Obes Relat Dis 7:691-696
24. Scopinaro N, Gianetta E, Pandolfo N et al (1976) Bilio-pancreatic bypass. Proposal and preliminary experimental study of a new type of operation for the functional surgical treatment of obesity. Minerva Chir 31:560-566
25. Scopinaro N, Gianetta E, Civalleri D et al (1979) Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg 66:618-620
26. Scopinaro N, Gianetta E, Civalleri D et al (1980) Two years of clinical experience with biliopancreatic bypass for obesity. Am J Clin Nutr 33:506-514
27. Marceau P, Biron S, St Georges R et al (1991) Biliopancreatic diversion with gastrectomy as surgical treatment of morbid obesity. Obes Surg 1:381-387
28. Marceau P, Hould FS, Simard S et al (1998) Biliopancreatic diversion with duodenal switch. World J Surg 22:947- 954
29. Biertho L, Lebel S, Marceau S et al (2011) Perioperative complications in a consecutive series of 1000 duodenal switches. Surg Obes Relat Dis [Epub ahead of print]
30. Marceau P, Biron S, Hould FS et al (2007) Duodenal switch: long-term results. Obes Surg 17:1421-1430
31. Scopinaro N (2006) Biliopancreatic diversion: mechanisms of action and long-term results. Obes Surg 16:683- 689
32. Herron DM (2004) Biliopancreatic diversion with duodenal switch vs. gastric bypass for severe obesity. J Gastrointest Surg 8:406-407
33. Scopinaro N, Adami GF, Papadia FS et al (2011) The effects of biliopancreatic diversion on type 2 diabetes mellitus in patients with mild obesity (BMI 30- 35 kg/m2) and simple overweight (BMI 25-30 kg/m2): a prospective controlled study. Obes Surg 21:880-888
34. Scopinaro N, Adami GF, Papadia FS et al (2011) Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25-35. Ann Surg 253:699-703
35. Topart P, Becouarn G, Salle A (2011) Five-year follow-up after biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis 7:199-205
36. Cho EY, Kemmet O, Frenken M (2011) Biliopancreatic diversion with duodenal switch in patients with type 2 diabetes mellitus: is the chance of complete remission dependent on therapy and duration of insulin treatment? Obes Facts 4(Suppl 1):18-23
37. Scopinaro N, Marinari GM, Camerini GB et al (2005) Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study. Diabetes Care 28:2406-2411
38. Scopinaro N (2011) Thirty-five years of biliopancreatic diversion: notes on gastrointestinal physiology to complete the published information useful for a better understanding and clinical use of the operation. Obes Surg. DOI 10.1007/s11695-011-0554-3
39. Rutledge R (2001) The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg 11:276-280
40. Lee W-J, Yu P-J, Wang W et al (2005) Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity. Ann Surg 242:20-28
41. Mezhir JJ, Gonen M, Ammori JB et al (2011) Treatment and outcome of patients with gastric remnant cancer after resection for peptic ulcer disease. Ann Surg Oncol 18:670-676
42. Toftgaard C (1989) Gastric cancer after peptic ulcer surgery. A historic prospective cohort investigation. Ann Surg 210:159-164
43. Viste A, Bjornestad E, Opheim P et al (1986) Risk of carcinoma following gastric operations for benign disease. A historical cohort study of 3470 patients. Lancet 2:502-505
44. Franco JV, Ruiz PA, Palermo M et al (2011) A review of studies comparing three laparoscopic procedures in bariatric surgery: sleeve gastrectomy, Roux-en-Y gastric bypass and adjustable gastric banding. Obes Surg 21:1458-1468
45. Karamanakos SN, Vagenas K, Kalfarentzos F et al (2008) Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 247:401-407
46. Peterli R, Wolnerhanssen B, Peters T et al (2009) Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg 250:234-241
47. Weiner RA, Weiner S, Pomhoff I et al (2007) Laparoscopic sleeve gastrectomy-influence of sleeve size and resected gastric volume. Obes Surg 17:1297-1305
48. Fischer LJ, Jacobsen G, Wong B et al (2009) NOTES laparoscopic-assisted transvaginal sleeve gastrectomy in humans-description of preliminary experience in the United States. Surg Obes Relat Dis 5:633-636
49. Saber AA, Elgamal MH, Itawi EA et al (2008) Single incision laparoscopic sleeve gastrectomy (SILS): a novel technique. Obes Surg 18:1338-1342
50. Peterli R, Steinert RE, Woelnerhanssen B et al (2012) Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and Sleeve Gastrectomy: a randomized, prospective trial. Obes Surg (in press)
51. Himpens J, Dobbeleir J, Peeters G (2010) Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg 252:319-324
52. Basso N, Casella G, Rizzello M et al (2011) Laparoscopic sleeve gastrectomy as first stage or definitive intent in 300 consecutive cases. Surg Endosc 25:444-449
53. Jacobs M, Bisland W, Gomez E et al (2010) Laparoscopic sleeve gastrectomy: a retrospective review of 1- and 2-year results. Surg Endosc 24:781-785
54. Shah PS, Todkar JS, Shah SS (2010) Effectiveness of laparoscopic sleeve gastrectomy on glycemic control in obese Indians with type 2 diabetes mellitus. Surg Obes Relat Dis 6:138-141
55. Vidal J, Ibarzabal A, Nicolau J et al (2007) Short-term effects of sleeve gastrectomy on type 2 diabetes mellitus in severely obese subjects. Obes Surg 17:1069-1074
56. Lee WJ, Chong K, Ser KH et al (2011) Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg 146:143-148
57. Kunath U, Memari B (1995) Laparoscopic gastric banding for treatment of pathologic obesity. Chirurg 66:1263-1267
58. Romy S, Donadini A, Giusti V et al (2012) Roux-en-Y gastric bypass vs gastric banding for morbid obesity: A case-matched study of 442 patients. Arch Surg (in press)
59. Wolnerhanssen BK, Peters T, Kern B et al (2008) Predictors of outcome in treatment of morbid obesity by laparoscopic adjustable gastric banding: results of a prospective study of 380 patients. Surg Obes Relat Dis 4:500-506
60. Stroh C, Hohmann U, Schramm H et al (2011) Fourteen-year long-term results after gastric banding. J Obes 2011:128451
61. Van Nieuwenhove Y, Ceelen W, Stockman A et al (2011) Long-term results of a prospective study on laparoscopic adjustable gastric banding for morbid obesity. Obes Surg 21:582-587
62. Dixon JB, Murphy DK, Segel JE et al (2012) Impact of laparoscopic adjustable gastric banding on type 2 diabetes. Obes Rev 13:57-67
63. Sjostrom L, Lindroos AK, Peltonen M et al (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683-2693
64. Bult MJF, Van Dalen T, Muller AF (2008) Surgical treatment of obesity. Eur J Endocrinol 158:135-145
65. Sjostrom L, Peltonen M, Jacobson P et al (2012) Bariatric surgery and long-term cardiovascular events. JAMA 307:56-65
66. Bueter M, Laurenius A, Lutz TA et al (2011) Untersuchungen zur Rolle der mechanischen Restriktion nach Magenbypass-Operation. Deutsche Gesellschaft für Chirurgie, Tagungskongress, München 3. bis 6. Mai 2011
67. Stefater MA, Perez-Tilve D, Chambers AP et al (2010) Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity. Gastroenterology 138:2426-2436
68. Madan AK, Tichansky DS, Phillips JC (2007) Does pouch size matter? Obes Surg 17:317-320
69. Ashrafian H, Athanasiou T, Li JV et al (2011) Diabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass. Obes Rev 12:257-272
70. Ashrafian H, Le Roux CW (2009) Metabolic surgery and gut hormones - a review of bariatric entero-humoral modulation. Physiol Behav 97:620-631
71. Bueter M, Le Roux CW (2011) Gastrointestinal hormones, energy balance and bariatric surgery. Int J Obes (Lond) 35(Suppl 3):35-39
72. Bueter M, Seyfried F, Germer CT (2010) Why patients lose weight after bariatric operations. Zentralbl Chir 135:28-33
73. Bueter M, Ashrafian H, Le Roux CW (2009) Mechanisms of weight loss after gastric bypass and gastric banding. Obes Facts 2:325-331
74. Le Roux CW, Bueter M, Theis N et al (2011) Gastric bypass reduces fat intake and preference. Am J Physiol Regul Integr Comp Physiol 301:R1057-1066
75. Richardson BE, Vander Woude EA, Sudan R et al (2004) Altered olfactory acuity in the morbidly obese. Obes Surg 14:967-969
76. Li JV, Ashrafian H, Bueter M et al (2011) Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut 60:1214-1223
77. Clément K (2011) Bariatric surgery, adipose tissue and gut microbiota. Int J Obes 35:S7-S15
78. Li JV, Ashrafian H, Bueter M et al. (2011) Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut 60:1214-1223
79. Bueter M, Lowenstein C, Ashrafian H et al (2010) Vagal sparing surgical technique but not stoma size affects body weight loss in rodent model of gastric bypass. Obes Surg 20:616-622
80. Sundbom M, Holdstock C, Engstrom BE et al (2007) Early changes in ghrelin following Roux-en-Y gastric bypass: influence of vagal nerve functionality? Obes Surg 17:304-310
81. Friedman MN, Sancetta AJ, Magovern GJ (1955) The amelioration of diabetes mellitus following subtotal gastrectomy. Surg Gynecol Obstet 100:201-204
82. Lee WJ, Chong K, Chen CY et al (2011) Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2. Obes Surg 21:889-895
83. Lee WJ, Wang W, Lee YC et al (2008) Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI>35 and <35 kg/m2. J Gastrointest Surg 12:945-952
84. Cohen R, Pinheiro JS, Correa JL et al (2006) Laparoscopic Roux-en-Y gastric bypass for BMI (35 kg/m2): a tailored approach. Surg Obes Relat Dis 2:401-404
85. Tinoco A, El-Kadre L, Aquiar L et al (2011) Short-term and mid-term control of type 2 diabetes mellitus by laparoscopic sleeve gastrectomy with ileal interposition. World J Surg 35:2238-2244
86. Kumar KV, Ugale S, Gupta N et al (2009) Ileal interposition with sleeve gastrectomy for control of type 2 diabetes. Diabetes Technol Ther 11:785-789
87. De Paula AL, Macedo AL, Mota BR et al (2009) Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21-29. Surg Endosc 23:1313-1320
88. Klein S, Fabbrini E, Patterson BW et al (2012) Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes. Obesity (in press)
89. Geloneze B, Geloneze SR, Fiori C et al (2009) Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion. Obes Surg 19:1077-1083
90. Kindel TL, Yoder SM, Seeley RJ et al (2009) Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor-mediated mechanism. J Gastrointest Surg 13:1762-1772
91. Rubino F, Marescaux J (2004) Effect of duodenal jejunal exclusion in a non-obese animal model of type 2 diabetes. Ann Surg 239:1-11
92. Culnan DM, Albaugh V, Sun M et al (2010) Ileal interposition improves glucose tolerance and insulin sensitivity in the obese Zucker rat. Am J Physiol Gastrointest Liver Physiol 299:G751-760
93. Cummings BP, Strader AD, Stanhope KL et al (2010) Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat. Gastroenterology 138:2437-2446
94. Wang TT, Hu SY, Gao HD et al (2008) Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1. Ann Surg 247:968-975